Peabody Energy Corp. faces a securities fraud class action with an Aug. 24 lead plaintiff deadline over delays at its Centurion metallurgical coal mine.
"Peabody's overly optimistic March 2026 Centurion ramp-up date and promises regarding the Company's inflated guidance fell short of reality when numerous issues at Centurion caused a significant delay to the mine's ramp-up," Glancy Prongay Wolke & Rotter LLP said in the complaint.
The class period runs from Oct. 14, 2024 to May 4, 2026. On March 30, 2026, Peabody lowered guidance for Centurion's first-quarter output due to commissioning challenges, sending shares down $3.82, or 9.7 percent, to $35.68. On May 5, the company disclosed it had failed to fully ramp up Centurion by March and cut full-year metallurgical segment volume guidance, sending shares down $1.52, or 5.7 percent, to $25.00.
The complaint alleges violations of Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5. Investors who purchased BTU securities during the class period must move the court by Aug. 24 to seek appointment as lead plaintiff. The class has not yet been certified, and investors may retain counsel of their choice or remain absent class members. Appointment as lead plaintiff is not required to participate in any potential recovery.
Multiple firms have issued similar notices, including Schall, Brown & Schwartz LLP and The Gross Law Firm. Glancy Prongay Wolke & Rotter was ranked second in total investor recoveries by Institutional Shareholder Services Securities Class Action Services in 2025 and was named one of Law360's Securities Groups of the Year. The firm's past successes have been covered by The Wall Street Journal, Reuters, Bloomberg Businessweek and Barron's.
The two disclosure events cut Peabody's share price by roughly 30 percent from the March 30 close to the May 5 close, eroding investor confidence in the company's operational guidance. The Aug. 24 lead plaintiff deadline is the next milestone for investors weighing participation in the action.
This article is for informational purposes only and does not constitute investment advice.